HEMATOLOGICAL AND GENETIC-STUDIES ON CML PATIENTS DURING TREATMENT WITH RECOMBINANT INTERFERON-ALPHA-2

被引:0
|
作者
GASTL, G
LEITER, E
AULITZKY, W
TILG, H
VONLUTTICHAU, I
RAPP, U
HUBER, C
机构
[1] UNIV INNSBRUCK, INNERE MED KLIN, KLIN IMMUNOBIOL ABT, A-6020 INNSBRUCK, AUSTRIA
[2] NCI, FREDERICK CANC RES FACIL, FREDERICK, MD 21701 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:67 / 67
页数:1
相关论文
共 50 条
  • [21] MODULATION OF GRANULOCYTE OXIDATIVE RESPONSE BY RECOMBINANT INTERFERON-ALPHA-2 AND GAMMA
    KAPP, A
    KIRCHNER, H
    WOKALEK, H
    SCHOPF, E
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1986, 278 (04) : 274 - 276
  • [22] PRODUCTION AND INVIVO BIOLOGIC ACTIONS OF RECOMBINANT MOUSE INTERFERON-ALPHA-2
    DRON, M
    TOVEY, MG
    MAURY, C
    EID, P
    MEYER, F
    GRESSER, I
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 1989, 3 (01): : 13 - 19
  • [23] ORAL-ADMINISTRATION OF HUMAN RECOMBINANT INTERFERON-ALPHA-2 IN RATS
    PAULESU, L
    CORRADESCHI, F
    NICOLETTI, C
    BOCCI, V
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 46 (03) : 199 - 202
  • [24] IMMUNOLOGICAL FINDINGS IN PATIENTS WITH SUPERFICIAL BLADDER-CANCER DURING HUMAN INTERFERON-ALPHA-2 TREATMENT
    GRUPS, JW
    FROHMULLER, HGW
    ACKERMANN, R
    UROLOGIA INTERNATIONALIS, 1985, 40 (06) : 301 - 306
  • [25] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ANALYSIS OF RECOMBINANT INTERFERON-ALPHA-2 AND INTERFERON-ALPHA-2 ANALOG PROTEINS PURIFIED BY IMMUNOABSORBTION CHROMATOGRAPHY
    FARROW, LR
    PATERSON, DS
    FITTON, JE
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1986, 14 (06) : 1183 - 1184
  • [26] IMMUNOMODULATION BY RECOMBINANT INTERFERON-ALPHA-2 IN A PHASE-I TRIAL IN PATIENTS WITH LYMPHOPROLIFERATIVE MALIGNANCIES
    OZER, H
    GAVIGAN, M
    OMALLEY, J
    THOMPSON, D
    DADEY, B
    NUSSBAUMBLUMENSON, A
    SNIDER, C
    RUDNICK, S
    FERRARESI, R
    NORRED, S
    HAN, T
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1983, 2 (06): : 499 - 515
  • [27] TREATMENT WITH NATURAL HUMAN INTERFERON ALPHA OF A CML-PATIENT WITH ANTIBODIES TO RECOMBINANT INTERFERON ALPHA-2B
    FREUND, M
    VONWUSSOW, P
    KNUVERHOPF, J
    MOHR, H
    POHL, U
    EXERIEDE, G
    LINK, H
    WILKE, HJ
    POLIWODA, H
    BLUT, 1988, 57 (05): : 311 - 315
  • [28] Treatment of children with chronic hepatites B and C by recombinant interferon-alpha-2 in rectal suppositoria (viferon)
    Uchaikin, VF
    Nisevich, NI
    Cherednichenko, TV
    Malinovskaya, VV
    Kovalev, OV
    Kharlamova, FS
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 431 - 431
  • [29] INTERFERON-ALPHA-2 TREATMENT OF METASTASIZING MALIGNANT-MELANOMA
    LANDTHALER, M
    GEYER, C
    PAPENDICK, U
    BRAUNFALCO, O
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, 112 (23) : 919 - 921
  • [30] TOXIC EFFECTS OF INTERFERON-ALPHA-2 TREATMENT - PRELIMINARY DATA
    IAFFAIOLI, RV
    PAGLIARULO, C
    LAMURA, G
    DAVINO, M
    PEZZULLO, A
    BIANCO, AR
    TUMORI, 1986, 72 (06) : 711 - 711